z-logo
open-access-imgOpen Access
COST MINIMIZATION ANALYSIS OF ORAL VALGANCICLOVIR VERSUS INTRAVENOUS AND ORAL GANCICLOVIR IN THE PREVENTION OF CYTOMEGALOVIRUS INFECTION AND DISEASE IN SOLID ORGAN TRANSPLANT RECIPIENTS
Author(s) -
F Oppenheimer,
María Victoria Rubio Rubio,
S Magaz,
Xavier Badía
Publication year - 2004
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/00007890-200407271-01309
Subject(s) - valganciclovir , ganciclovir , medicine , regimen , clinical trial , transplantation , cytomegalovirus , surgery , intensive care medicine , human cytomegalovirus , immunology , herpesviridae , viral disease , virus

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here